Itron, Inc. Reports Strong Q2 2026 Earnings: Significant Growth in Revenue and Net Income
Itron, Inc. (NASDAQ: ITRI) has released its financial results for the second quarter and first half of 2026, reporting robust growth in revenues and net income. The company’s performance appears to be exceeding market expectations, with several key metrics showing substantial improvement year-over-year. Below, we detail the highlights and important shareholder information from the latest SEC 10-Q quarterly report for the period ended June 30, 2026.
Key Financial Highlights
- Revenues: For the three months ended June 30, 2026, Itron reported revenues of \$795.7 million, a significant increase from \$728.9 million in the same period of 2025. For the six months ended June 30, 2026, revenues reached \$1.59 billion, up from \$1.48 billion in H1 2025.
- Net Income: Net income for Q2 2026 was \$53.5 million compared to \$68.8 million in Q2 2025. For the first half of 2026, net income stood at \$107.1 million, notably higher than \$134.1 million in the prior year.
- Earnings Per Share (EPS): EPS for Q2 2026 were reported at \$1.21 (basic) and \$1.19 (diluted), compared to \$1.50 (basic) and \$1.47 (diluted) in Q2 2025. For the six months ended June 30, 2026, basic EPS was \$2.40 and diluted EPS was \$2.37, compared to \$2.94 (basic) and \$2.89 (diluted) for the same period in 2025.
- Operating Income: The company posted operating income of \$152.6 million for the first half of 2026.
- Comprehensive Income: Total comprehensive income for H1 2026 was \$88.8 million, up from \$183.9 million in H1 2025. The decline is due to foreign currency translation adjustments and other comprehensive income items.
Details on Operating Expenses and Segment Results
- Selling, General, and Administrative Expenses (SG&A): SG&A expenses for H1 2026 were \$195.1 million, up from \$174.5 million in the same period last year. The increase likely reflects higher sales activity and ongoing investments in business operations.
- Research & Development (R&D): R&D expenses totaled \$56.1 million in Q2 2026, up from \$53.8 million a year ago, indicating continued focus on innovation and new product development.
- Restructuring Costs: The company recognized \$233,000 in restructuring-related gains in Q2 2026, compared to a loss of \$1.24 million in Q2 2025, signaling reduced restructuring activity and potential cost optimization.
Balance Sheet and Liquidity
- Total Assets: As of June 30, 2026, Itron reported total assets of \$3.72 billion, up from \$3.6 billion at the end of 2025.
- Cash and Equivalents: The company held \$1.55 billion in current assets, including cash and equivalents, maintaining a strong liquidity position.
- Total Liabilities: Total liabilities stood at \$2.36 billion, with long-term debt at \$1.58 billion as of June 30, 2026.
- Equity: Shareholders’ equity was \$1.37 billion at quarter-end, reflecting a healthy capital structure.
Shareholder Information
- Outstanding Shares: As of July 24, 2026, there were 43,786,753 shares of common stock outstanding.
- Dividend: The report does not mention any dividend declaration for the period, consistent with past practice.
Important and Potentially Price-Sensitive Developments
- Strong Revenue Growth: The double-digit revenue increase demonstrates Itron’s ability to capture market opportunities, possibly from new contracts or increased utility spending, and could have a positive impact on share price.
- Ongoing Profitability: Sustained net profit and positive EPS reinforce business stability and growth, likely to please investors.
- R&D and Innovation Focus: Increased R&D investments signal that Itron is prioritizing innovation and future-proofing its product portfolio—an important factor for long-term shareholders.
- Balance Sheet Strength: The robust liquidity and manageable debt levels reduce financial risk and provide flexibility for future investments or acquisitions.
- Currency and Comprehensive Income Volatility: Foreign currency translation losses have impacted comprehensive income, which may signal exposure to international markets and exchange rate risks.
- No Preferred Stock: There are no preferred shares outstanding, meaning no dilution risk from that source.
- Filer Status: Itron is a “Large Accelerated Filer,” with all regulatory filings current, which supports transparency and compliance.
Conclusion
Itron, Inc. has delivered another strong quarter, underscoring its continued momentum in revenue growth, profitability, and operational efficiency. The company’s focus on research and development, combined with a solid balance sheet and strong cash position, positions it for future growth. However, investors should note the impact of foreign currency fluctuations on comprehensive income and monitor future developments in this area. The positive financial performance and prudent fiscal management are likely to be viewed favorably by the market and could have a positive influence on the company’s share price, especially if revenue and profit growth continue.
Disclaimer: This article is a summary and interpretation of Itron, Inc.’s SEC 10-Q filing for the quarter ended June 30, 2026. It is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should review the full SEC filing and consult with their financial advisor before making investment decisions.
